About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Expert Opinion on Drug Discovery
›
top-articles
Expert Opinion on Drug Discovery
5.0
(top 5%)
impact factor
1.6K
(top 10%)
papers
46.1K
(top 10%)
citations
84
(top 10%)
h
-index
6.3
(top 5%)
impact factor
2.0K
all documents
49.6K
doc citations
138
(top 5%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities
Expert Opinion on Drug Discovery
2015
2,907
2
Lipophilicity in drug discovery
Expert Opinion on Drug Discovery
2010
643
3
The influence of lipophilicity in drug discovery and design
Expert Opinion on Drug Discovery
2012
499
4
Virtual screening with AutoDock: theory and practice
Expert Opinion on Drug Discovery
2010
462
5
Advances in structure-based drug discovery of carbonic anhydrase inhibitors
Expert Opinion on Drug Discovery
2017
356
6
Molecular dynamics simulations and novel drug discovery
Expert Opinion on Drug Discovery
2018
292
7
Fluorescence polarization assays in small molecule screening
Expert Opinion on Drug Discovery
2011
285
8
The importance of plasma protein binding in drug discovery
Expert Opinion on Drug Discovery
2007
274
9
Ligand efficiency indices for effective drug discovery
Expert Opinion on Drug Discovery
2007
253
10
On some aspects of validation of predictive quantitative structure–activity relationship models
Expert Opinion on Drug Discovery
2007
250
11
Halogen bonding for rational drug design and new drug discovery
Expert Opinion on Drug Discovery
2012
249
12
Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors
Expert Opinion on Drug Discovery
2013
229
13
An overview of molecular hybrids in drug discovery
Expert Opinion on Drug Discovery
2016
228
14
Gateway®recombinational cloning: a biological operating system
Expert Opinion on Drug Discovery
2007
217
15
The multicellular tumor spheroid model for high-throughput cancer drug discovery
Expert Opinion on Drug Discovery
2012
215
16
The impact of click chemistry in medicinal chemistry
Expert Opinion on Drug Discovery
2012
210
17
The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy
Expert Opinion on Drug Discovery
2019
204
18
Use of machine learning approaches for novel drug discovery
Expert Opinion on Drug Discovery
2016
187
19
A renaissance of neural networks in drug discovery
Expert Opinion on Drug Discovery
2016
182
20
The utilization of spirocyclic scaffolds in novel drug discovery
Expert Opinion on Drug Discovery
2016
179
21
Advances in the development of hybrid anticancer drugs
Expert Opinion on Drug Discovery
2013
177
22
Organs-on-a-chip: a new tool for drug discovery
Expert Opinion on Drug Discovery
2014
175
23
The dynamics of drug-target interactions: drug-target residence time and its impact on efficacy and safety
Expert Opinion on Drug Discovery
2010
173
24
The challenge of selecting protein kinase assays for lead discovery optimization
Expert Opinion on Drug Discovery
2008
171
25
Rodent models for Alzheimer’s disease drug discovery
Expert Opinion on Drug Discovery
2015
170
26
The structural modification of natural products for novel drug discovery
Expert Opinion on Drug Discovery
2017
169
27
Broad-spectrum coronavirus antiviral drug discovery
Expert Opinion on Drug Discovery
2019
168
28
Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics
Expert Opinion on Drug Discovery
2020
168
29
The design of semi-synthetic and synthetic glycoconjugate vaccines
Expert Opinion on Drug Discovery
2011
167
30
Promise and challenges in drug discovery and development of hybrid anticancer drugs
Expert Opinion on Drug Discovery
2009
164
31
An overview of quinoline as a privileged scaffold in cancer drug discovery
Expert Opinion on Drug Discovery
2017
164
32
Advances in computational methods to predict the biological activity of compounds
Expert Opinion on Drug Discovery
2010
163
33
In situclick chemistry: a powerful means for lead discovery
Expert Opinion on Drug Discovery
2006
159
34
An overview of molecular fingerprint similarity search in virtual screening
Expert Opinion on Drug Discovery
2016
158
35
An overview of spirooxindole as a promising scaffold for novel drug discovery
Expert Opinion on Drug Discovery
2020
157
36
Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders
Expert Opinion on Drug Discovery
2009
153
37
Polyether ionophores: broad-spectrum and promising biologically active molecules for the control of drug-resistant bacteria and parasites
Expert Opinion on Drug Discovery
2009
153
38
Going further than Lipinski's rule in drug design
Expert Opinion on Drug Discovery
2012
151
39
Recent applications of click chemistry in drug discovery
Expert Opinion on Drug Discovery
2019
151
40
Rhodanine as a scaffold in drug discovery: a critical review of its biological activities and mechanisms of target modulation
Expert Opinion on Drug Discovery
2012
148
41
How to design multi-target drugs
Expert Opinion on Drug Discovery
2007
141
42
Schistosomes: challenges in compound screening
Expert Opinion on Drug Discovery
2007
140
43
Drug discovery for a new generation of covalent drugs
Expert Opinion on Drug Discovery
2012
140
44
An overview of late-stage functionalization in today’s drug discovery
Expert Opinion on Drug Discovery
2019
140
45
Using zebrafish to assess the impact of drugs on neural development and function
Expert Opinion on Drug Discovery
2009
134
46
Animal models of chronic obstructive pulmonary disease
Expert Opinion on Drug Discovery
2014
130
47
Stabilization of protein-protein interactions in drug discovery
Expert Opinion on Drug Discovery
2017
129
48
Artificial intelligence in drug discovery: recent advances and future perspectives
Expert Opinion on Drug Discovery
2021
128
49
What has virtual screening ever done for drug discovery?
Expert Opinion on Drug Discovery
2008
126
50
Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery
Expert Opinion on Drug Discovery
2019
123
site/software ©
exaly
; All materials licenced under
CC by-SA
.